Menu Close

Articles on Generic drugs

Displaying 1 - 20 of 21 articles

Drug patents don’t necessarily spur companies to innovate so much as restrict access to their IP. Andrii Zastrozhnov/iStock via Getty Images Plus

Pharma’s expensive gaming of the drug patent system is successfully countered by the Medicines Patent Pool, which increases global access and rewards innovation

The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
From thalidomide to Viagra, drug repurposing salvaged failed treatments by giving them new targets. smartboy10/DigitalVision Vectors via Getty Images

Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier

Drug repurposing can redeem failed treatments and squeeze out new uses from others. But many pharmaceutical companies are hesitant to retool existing drugs without a high return on investment.
Generic drug names are assigned at the global level by the World Health Organization in conjunction with national naming authorities. (Shutterstock)

Generic drug names provide information for doctors, so why is Health Canada promoting the use of pharma brand names?

Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
Workers at India’s biggest syringe manufacturer ramp up production in September 2020 in race to meet COVID-19 vaccine-driven demand. Photo by SAJJAD HUSSAIN/AFP via Getty Images

Why India is banking on health diplomacy to grow African footprint

There are three broad sets of health-related opportunities and benefits that may shape the future of India-Africa relations.
Generic drugs can be a great way to save money, but a recent study shows there are risks involved. HQuality/Shutterstock.com

Why your generic drugs may not be safe and the FDA may be too lax

As drug prices soar, consumers look for cheaper generics. A recent study showed safety issues in some generics made abroad, however, suggesting that the FDA’s honor system may not be enough to ensure safety.
The rising costs of EpiPens has led to outrage. Rich Pedroncelli/AP

Drug prices: Where do we go after the Election?

The rising cost of drugs is more worrisome to most Americans than problems with Obamacare. Could proposals in California and Ohio help?

Top contributors

More